ASBP

Conviction 80HealthcareScan · Mon, Aug 10, 2026

Hanging man

ASBP$7.91+2.33%

ResistanceSupportVol 14

Vol MA14 40.05K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Aspire Biopharma Holdings, Inc.PHARMACEUTICAL PREPARATIONSwww.aspirebiolabs.com ↗

Price7.91

Change+2.33%

Gap+1.03%

Rel volume0.24×

Avg volume46.83K

Avg $ vol321.07K

SMA 206.91

SMA 506.34

SMA 2002.41

Price vs 50+24.67%

Price vs 200+228.17%

MA stackbullish

50/200 cross—

Supertrendup · 5.50

RSI (14)61

MACD hist0.06

MACD crossbull · 1d

Stoch %K / %D92 / 82

ADX (14)16

+DI / −DI21 / 18

RSI divergence—

MACD divergence—

ATR %+9.70%

ADR %10.29%

52w high7.91

52w low0.0519

From 52w high+0.00%

Above 52w low+15140.85%

New 52w highYes

SqueezeOff

Bollinger width36.02%

%B0.90

Donchian pos92.12%

Donchian high8.17

Donchian low4.87

AVWAP (52w high)7.05

vs AVWAP high+12.20%

AVWAP (52w low)0.4291

vs AVWAP low+1743.18%

OBV trendUp

Chaikin MF (20)0.11

Today vs 20d0.24×

Avg vol (14d)40.05K

Avg vol (20d)46.83K

Avg $ vol (20d)321.07K

Market cap10.25M

RS 3m (vs SPY)+4881.40%

RS 6m (vs SPY)+471.49%

RS line new highNo

Trend template8/8

Technical rank96.1

1 week+9.41%

1 month+31.61%

3 months+4175.68%

6 months+441.78%

1 year+2272.53%

YTD+5677.94%

P/E-0.42

P/B2.65

P/S—

P/FCF—

EPS-16.38

Div yield—

ROE-632.83%

ROA-343.97%

Debt/Eq—

Current2.26

EV/EBITDA—

Gross margin-1.87%

Net margin—

Rev growth—

EPS growth-1768.95%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value4.39M

Revenue28.35K

Net income-3.22M

Gross profit5.75K

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out1.3M

Employees—

ListedThu, Feb 20, 2025

Free float4.51M

Float %89.7%

Short interest118.3K

Days to cover2.0d

Short volume35.9%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank96.1 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmHanging man

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ASBP

All disclosures →

No recent disclosed trades by Congress in ASBP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ASBP

No recent insider (Form 4) filings in ASBP. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ASBP · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.